For premix quantities less than 1 lb. Mix the proper amount of premix with at least 10 lb of feed ingredients to make a preblend. Add the preblend to the remaining feed ingredients and mix thoroughly. Indications for Use Use Level of CLTC lb of CLTC 100 MR/ton CALVES–Milk Replacers or Starter Feeds For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline...
Chlortetracycline hydrochloride . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 g/lb
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For use in manufacturing medicated animal feeds only.
CAUTION: Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety.
Precautions such as the following should be considered: dust masks or respirators and protective clothing should be worn; dust-arresting equipment and adequate ventilation should be utilized; personal hygiene should be observed; wash before eating or leaving a work site; be alert for signs of allergic reactions–seek prompt medical treatment if such reactions are suspected.
For premix quantities less than 1 lb. Mix the proper amount of premix with at least 10 lb of feed ingredients to make a preblend. Add the preblend to the remaining feed ingredients and mix thoroughly.
Indications for Use | Use Level of CLTC | lb of CLTC 100 MR/ton |
CALVES–Milk Replacers or Starter Feeds For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline. | 10 mg/lb body weight daily Limit use to 5 days | 201 |
WARNING: At 10 mg/lb use level, withdraw 10 days before slaughter. A withdrawal period has not been established in preruminating calves. Do not use in calves to be processed for veal. | ||
1 Calf weighing 100 lb consuming 1 lb of dry starter feed or 1 lb of milk replacer mixed with one gallon of water. | ||
FOR USE IN DRY FEEDS ONLY.
NOT FOR USE IN LIQUID FEED SUPPLEMENTS.
NOT FOR HUMAN USE.
RESTRICTED DRUG (CALIFORNIA) – USE ONLY AS DIRECTED.
CLTC® is a registered trademark of Phibro Animal Health Corporation for chlortetracycline.
Phibro Animal Health Corporation, Teaneck, NJ 07660.
Net Weight 50 lb (22.7 kg)
Approved by FDA under NADA # 092-287
101-8033-08
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66104-6300-0 | CLTC 100 MR | 22.7 kg in 1 BAG | POWDER | 22.7 | 9 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66104-6300 | CLTC 100 MR (CHLORTETRACYCLINE HYDROCHLORIDE) POWDER [PHIBRO ANIMAL HEALTH] | 9 | 1 package rows | 20230721_f65a7756-a03e-481e-943b-fdc6c715a454.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHLORTETRACYCLINE HYDROCHLORIDE | ACTIVE INGREDIENT | O1GX33ON8R | 5 | |
| CHLORTETRACYCLINE | ACTIVE MOIETY | WCK1KIQ23Q | 5 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 66104-6300 | 66104-6300-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHLORTETRACYCLINE HYDROCHLORIDE | O1GX33ON8R | ACTIB |
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | PASTILLE / ORAL | 826 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | POWDER / VAGINAL | 430 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET / SUBLINGUAL | 115.78 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SPRAY, METERED / NASAL | 50 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRAVENOUS | 51.7 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRASPINAL | 75 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAVENOUS | 5 %w/v | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | LOZENGE / BUCCAL | NA | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SYRUP / ORAL | 620 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | POWDER, FOR SOLUTION / ORAL | NA | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, COATED / ORAL | 132 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | CONCENTRATE / ORAL | 400 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRATHECAL | 1925 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SOLUTION / INTRAVENOUS | 5.05 %w/v | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SOLUTION / ORAL | 2489 mg/5ml |
Adverse event summaries are temporarily unavailable. Other product information remains available.